Background: Sleep-related eating may occur in the context of mental illness, sleep disorders, or psychopharmacological treatment. Frequently, sleep-related eating leads to severe weight gain and, so far, there are no treatment options for the condition.
Case Presentation: We report the case of a 54-year-old white woman with depression, panic disorder, and sleep apnea under treatment with various antidepressants who developed severe sleep-related eating. Her sleep-related eating completely vanished after addition of agomelatine, it reoccurred after cessation of agomelatine, and vanished again after her re-exposure to another melatonergic drug, extended melatonin.
Conclusions: This case suggests that melatonergic drugs lead to relief from sleep-related eating, even when the condition occurs in the context of physical and mental disorders as well as psychopharmacological treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618723 | PMC |
| http://dx.doi.org/10.1186/s13256-017-1438-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Physical Activity, Sleep and Eating in Young People With Borderline Personality Disorder.
Personal Ment Health
February 2025
Behavioural Science Institute, Radboud University, Nijmegen, Netherlands.
Previous research suggests a connection between borderline personality disorder (BPD) and somatic comorbidities, underscoring the importance of lifestyle and health-related behaviour (LHRB) in the emergence of BPD. We investigated LHRBs-physical activity, sleeping and overeating-among young people at different BPD stages compared to a matched community sample. Furthermore, we explored whether problematic LHRBs intensify in later BPD stages.
View Article and Find Full Text PDFNurse-delivered brief behavioral treatment for insomnia in cancer survivors: a randomized controlled trial.
J Cancer Surviv
November 2024
Department of Biostatistics, University at Buffalo School of Public Health and Health Professions, The State University of New York, Buffalo, NY, USA.
Purpose: To determine the efficacy of nurse-delivered brief behavioral treatment for insomnia (BBTI) compared to an attention control, in a heterogeneous sample of cancer survivors to reduce insomnia symptom severity.
Methods: We recruited 132 participants from cancer care clinics, who had an Insomnia Severity Index (ISI) score ≥ 8. Participants were randomized into two groups: an experimental BBTI group and a healthy eating attention control group.
Interaction of Clock gene variants and behavioral parameters influences adiposity-related traits.
Chronobiol Int
December 2024
Molecular Biology and Human Genetics Laboratory, Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi, Pakistan.
Obesity, a major health concern, is influenced by an individual's genetic makeup and lifestyle factors (eating, sedentary lifestyle, and sleep disruptions) that affect circadian clock and metabolism. This study investigates the impact of Clock gene variants rs6843722 and rs4864548 on obesity measures in the Pakistani population. Genetic-behavior interaction studies have focused on Western populations, overlooking South Asians.
View Article and Find Full Text PDFTwo Cases of Sleep-related Dissociative Disorder with Episodes of Nocturnal Eating.
Sleep Sci
September 2024
Minnesota Regional Sleep Disorders Center, Departments of Psychiatry, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, Minnesota, United States.
Article Synopsis
- Sleep-related dissociative disorder (SRDD) is a psychiatric condition mostly affecting women, recognized since 1989 and officially classified in 2005, characterized by unusual dissociative episodes occurring during sleep transitions.
- Key features include sustained EEG wakefulness during episodes, observed in about half of cases, which typically follow disruptions in sleep stages.
- The report highlights two new cases of SRDD in women with histories of severe childhood abuse and "sleep phobia," emphasizing the association between SRDD, nocturnal eating behaviors, and various triggering factors.
Parasomnias and sleep-related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects.
J Sleep Res
September 2024
Service Pharmacie, AP-HP, GHU Paris Nord, DMU PRISME, Hôpital Bichat-Claude Bernard, Paris, France.
Article Synopsis
- Parasomnias and sleep-related movement disorders (SRMD) are sleep disorders that can be triggered by certain medications, and this study aimed to review the literature on this association from January 2020 to June 2023.
- Over 900 records were examined, identifying 73 drugs linked to common drug-induced parasomnias like nightmares and sleepwalking, as well as SRMDs such as restless legs syndrome and bruxism.
- The study discusses potential mechanisms behind these disorders related to various neurotransmitters, including the impact of antipsychotics, opioids, and medications affecting serotonin, noradrenergic, and dopamine pathways, highlighting gaps in drug labeling for these conditions.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!